RETHINKING AIDS HOMEPAGE




                A CRITIQUE OF THE EVIDENCE
                FOR THE ISOLATION OF HIV
                A SUMMARY OF THE VIEWS OF PAPADOPULOS ET. AL.

                The proposal that AIDS is caused by a unique, infectious
                retrovirus requires proof for the existence of such a
                retrovirus. Since the announcement of the discovery of certain
                laboratory phenomena claimed as proof of the existence of HIV we
                have critically analysed the data and have always maintained
                that no such proof exists [1-11].
                A virus is a microscopic particle of particular size and shape
                (morphology) which contains particular constituents (biochemical
                properties) and which is able to replicate only at the behest of
                living protoplasm, that is, a virus is an obligatory
                intracellular parasite. Replication of a virus-like particle is
                the property which defines the particle as being infectious,
                that is, virus-like particle + replication = virus. These
                defining data determine that the only way to prove the existence
                of a novel (new) virus is to (i) isolate viral-like particles,
                that is, first obtain the particles separate from everything
                else; (ii) determine their morphological characteristics; (iii)
                analyse their constituents (nucleic acid and proteins)
                demonstrating that such properties are those of retroviruses and
                are unique; (iv) prove that the particles are infectious, that
                is, when pure particles are introduced into non-infected cell
                cultures, new but identical particles appear. Only then can the
                viral-like particles be deemed to a virus. In the case of
                retroviruses, the steps in this procedure were developed over
                the half century that preceded the AIDS era and are described in
                Toplin and Sinoussi. [12,13]. These steps are:
                    1. Culture of putatively infected cells demonstrating that
                    such cultures contain retroviral-like particles, that is,
                    particles virtually spherical in shape with a diameter of
                    100-120nM and with "condensed inner bodies (cores)" and
                    surfaces "studded with projections (knobs)" [14].
                    2. Purification of a sample by ultracentrifugation through a
                    sucrose density gradient. A test tube containing a solution
                    of sucrose, ordinary table sugar, is prepared light at the
                    top but gradually becoming heavier towards the bottom. A
                    drop of supernatant (decanted) cell culture fluid is gently
                    placed on top of the sucrose column and the test-tube is
                    centrifuged for several hours at extremely high speeds. This
                    generates tremendous forces forcing any particles present
                    through the sugar solution until they reach a point where
                    their buoyancy prevents further penetration. For retroviral
                    particles this occurs where the density of the sucrose
                    solution reaches 1.16 gm/ml. At this the point the particles
                    concentrate or, to use virological terminology, this is
                    where the particles band. The 1.1 band is then selectively
                    extracted for further analysis.
                    3. Using the electron microscope (EM), photograph the 1.16
                    band proving there are particles of the correct morphology
                    and no other material.
                    4. Disrupt and analyse the constituents of such particles.
                    5. Introduce pure particles into a virgin culture and, by
                    repeating the above steps, prove that identical particles
                    are produced.
                To date, many electron micrographs of particles claimed to be
                retrovirus-like have been published. However, not one of these
                micrographs demonstrates particles satisfying both main
                morphological features of retroviral particles, that is, a
                diameter of 100-120nM and a surface studded with knobs. (HIV
                researchers are unanimous that the knobs contain a protein,
                gp120, which is essential for the first step in infection and
                replication, that is, for the particle to fuse with the membrane
                of an uninfected cell in order that the HIV particle with its
                'HIV RNA" gains access to the interior of the cell [15].
                To prove the existence of HIV, both Montagnier's group in 1983
                and Gallo's group in 1984 banded supernatant in sucrose density
                gradients. However, until March 1997, for unknown reasons,
                neither these groups nor anyone else had ever published an
                electron micrograph of the banded (purified) material to show
                which if any of the many different variety of particles seen in
                gross cell cultures [20] are present at 1.16 gm/ml. Indeed,
                until March this year it was not possible to know whether any
                structured material whatsoever was present at the density which
                defines retroviral particles. Nonetheless, from the time of the
                Montagnier and Gallo studies [16,17], the material from culture
                supernatants banding at 1.16 gm/ml has been regarded as pure HIV
                particles. Acting on this premis, the proteins which are present
                in this band and which react with antibodies present in the sera
                of AIDS patients are claimed to be the HIV proteins and the
                antibodies reacting with such proteins the HIV antibodies.
                Similarly, a particular portion of the RNA banding at 1.16 gm/ml
                is claimed to be the HIV genome. All these conclusions were
                drawn without ever proving that the proteins and RNA are
                structural elements of a particle, viral-like, retroviral-like
                or any other particle of any other kind, that is, without any
                scientific basis.
                New Data
                This March, two papers [18,19] were published with electron
                micrographs of sucrose density gradient banded material. In one
                of these papers the authors confirmed that:
                    "Virus to be used for biochemical and serological [using
                    "viral" proteins to test for antibodies in patients]
                    analyses or as an immunogen [to produce antibodies in
                    animals and test patients for "viral" proteins] is
                    frequently prepared by centrifugation through sucrose
                    density gradients. The fractions containing viral antigen
                    [proteins] and/or infectivity are considered to contain a
                    population of relatively pure viral particles" [19] (italics
                    ours).
                However, to the contrary, the data in these papers support our
                claim that the existence of HIV is unproven:
                1. The authors of both papers concede that the particles which
                are present in the banded material and which are said to be HIV
                represent only a very small fraction of the total material.
                Gelderblom et al. state that the material contains "an excess of
                [cellular] vesicles with a size range 50-500nm, as opposed to a
                minor population of virus particles...cellular vesicles
                appear...to be a major contaminant of HIV preparations enriched
                by sucrose gradient centrifugation".
                2. For the small number of particles deemed to be "HIV" no
                evidence is given that they are even a retrovirus-like particle.
                Indeed, to the contrary:
                (a) the particles do not appear to have surface spikes (knobs),
                although the possibility that such projections may be present
                cannot be excluded. (However, in other papers published by many
                researchers including Gelderblom and his associates such
                projections are noted to be absent [14,20];
                (b) the particles referred to as "HIV" are not spherical and
                have diameters exceeding 100-120 nM. In the EM in Gluschankof et
                al. [19] there are arrows pointing to five "HIV" particles
                devoid of surface projections whose dimensions are 121 X 145;
                121 X 169; 121 X 145, 121 X 145 and 133 X 145 nM respectively.
                In Bess et al. [18] there are a total of six "HIV particles"
                also devoid of surface projections whose dimensions are 160 X
                240; 200 X 240; 280 X 280; 208 X 250; 167 X 250 and 250 X 292
                and nM respectively.
                Thus, by definition, the particles cannot be retroviral-like
                particles and even less, a unique retrovirus, HIV. Furthermore,
                the particles noted by Gluschankof et al. and Bess et al. cannot
                be the same particle. Indeed, the method adopted by all HIV
                researchers for proving the existence of HIV, that is, excluding
                proof based on purification of particles with retroviral
                morphology shown capable of faithful replication but rather by
                detection of antibody/protein reactions, does not satisfy any
                scientific principle and defies common sense.
                Eleni Papadopulos-Eleopulos
                Department of Medical Physics
                Royal Perth Hospital
                Perth, Western Australia
                August 1997

                Voice int + 618 92243221
                Fax int + 618 92243511
                Email: [EMAIL PROTECTED]
                References
                1. Papadopulos-Eleopulos E. (1982). A Mitotic Theory. J. Theor.
                Biol. 96:741-758
                2. Papadopulos-Eleopulos E. (1988). Reappraisal of AIDS: Is the
                oxidation caused by the risk factors the primary cause? Medical
                Hypotheses 25:151-162.
                3. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM. (1992).
                Oxidative Stress, HIV and AIDS. Res. Immunol. 143:145-148.
                4. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM. (1993).
                Is a Positive Western Blot Proof of HIV Infection?
                Bio/Technology 11(June):696-707.
                5. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM. (1993).
                Has Gallo proven the role of HIV in AIDS? Emerg. Med.
                [Australia] 5(No 2):113-123.
                6. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Causer
                D, Hedland-Thomas B, Page B. (1994). A critical analysis of the
                HIV-T4-cell-AIDS hypothesis. Genetica 95:5-24.
                7. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Causer
                D. (1995). A reply to Wei and Ho. Unpublished letter to Nature .

                8. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Causer
                D. (1995). Fator VIII, HIV and AIDS in haemophiliacs: an
                analysis of their relationship. Genetica 95:25-50.
                9. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Bialy
                H. (1995). AIDS in Africa: Distinguishing fact and fiction.
                World J. Microbiol. Biotechnol. 11:135-143.
                10. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM.
                (1996). Virus Challenge. Continuum 4:24-27.
                11. Turner VF. (1990). Reducing agents and AIDS--Why are we
                waiting? Med. J. Aust. 153:502.
                12. Toplin I. (1973). Tumor Virus Purification using Zonal
                Rotors. Spectra No. 4:225-235.
                13. Sinoussi F, Mendiola L, Chermann JC. (1973). Purification
                and partial differentiation of the particles of murine sarcoma
                virus (M. MSV) according to their sedimentation rates in sucrose
                density gradients. Spectra 4:237-243.
                14. Gelderblom HR, Ozel M, Hausmann EHS, Winkel T, Pauli G, Koch
                MA. (1988). Fine Structure of Human Immunodeficiency Virus
                (HIV), Immunolocalization of Structural Proteins and Virus-Cell
                Relation. Micron Microscopica 19:41-60.
                15. Levy JA. (1996). Infection by human immunodeficiency
                virus-CD4 is not enough. NEJM 335:1528-1530.
                16. Barre-Sinoussi F, Chermann JC, Rey F. (1983). Isolation of a
                T-Lymphotrophic Retrovirus from a patient at Risk for Acquired
                Immune Deficiency Syndrome (AIDS). Science 220:868-871.
                17. Gallo RC, Salahuddin SZ, Popovic M, et al.. (1984). Frequent
                Detection and Isolation of Cytopathic Retroviruses (HTLV-III)
                from Patients with AIDS and at Risk for AIDS. Science
                224:500-503.
                18. Bess JW, Gorelick RJ, Bosche WJ, Henderson LE, Arthur LO.
                (1997). Microvesicles are a source of contaminating cellular
                proteins found in purified HIV-1 preparations. Virol.
                230:134-144.
                19. Gluschankof P, Mondor I, Gelderblom HR, Sattentau QJ.
                (1997). Cell membrane vesicles are a major contaminant of
                gradient-enriched human immunodeficiency virus type-1
                preparations. Virol. 230:125-133.
                20. Hockley DJ, Wood RD, Jacobs JP. (1988). Electron Microscopy
                of Human Immunodeficiency Virus. J. Gen. Virol. 69:2455-2469.

            RETHINKING AIDS HOMEPAGE


Reply via email to